GNTA
Price
$3.16
Change
+$0.04 (+1.28%)
Updated
Sep 26 closing price
Capitalization
57.8M
PTHS
Price
$33.80
Change
+$0.56 (+1.68%)
Updated
Sep 26 closing price
Capitalization
103.48M
67 days until earnings call
Interact to see
Advertisement

GNTA vs PTHS

Header iconGNTA vs PTHS Comparison
Open Charts GNTA vs PTHSBanner chart's image
Genenta Science SpA
Price$3.16
Change+$0.04 (+1.28%)
Volume$6.26K
Capitalization57.8M
Pelthos Therapeutics
Price$33.80
Change+$0.56 (+1.68%)
Volume$14.86K
Capitalization103.48M
GNTA vs PTHS Comparison Chart in %
Loading...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNTA vs. PTHS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Buy and PTHS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (GNTA: $3.16 vs. PTHS: $33.80)
Brand notoriety: GNTA and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 62% vs. PTHS: 120%
Market capitalization -- GNTA: $57.8M vs. PTHS: $103.48M
GNTA [@Biotechnology] is valued at $57.8M. PTHS’s [@Biotechnology] market capitalization is $103.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 1 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • GNTA’s FA Score: 1 green, 4 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, GNTA is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNTA’s TA Score shows that 5 TA indicator(s) are bullish while PTHS’s TA Score has 3 bullish TA indicator(s).

  • GNTA’s TA Score: 5 bullish, 3 bearish.
  • PTHS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GNTA is a better buy in the short-term than PTHS.

Price Growth

GNTA (@Biotechnology) experienced а +10.49% price change this week, while PTHS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

PTHS is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($103M) has a higher market cap than GNTA($57.8M). PTHS YTD gains are higher at: 427.301 vs. GNTA (-27.356).
GNTAPTHSGNTA / PTHS
Capitalization57.8M103M56%
EBITDAN/A-8.54M-
Gain YTD-27.356427.301-6%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A59.2K-
Total DebtN/A2.31M-
TECHNICAL ANALYSIS
Technical Analysis
GNTAPTHS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAVHY23.380.33
+1.45%
Tav Havalimanlari Holding AS
EDCFF0.20N/A
N/A
ENEL GENERACION COSTANERA S A
OPTHF0.21N/A
N/A
OPTIMI HEALTH CORP.
CSLUF11.59N/A
N/A
CSLM Acquisition Corp.
ACDSF2.09-0.12
-5.26%
Ascendas Real Estate Investment Trust

GNTA and

Correlation & Price change

A.I.dvisor tells us that GNTA and WVE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNTA and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
+1.13%
WVE - GNTA
30%
Poorly correlated
+2.10%
BEIGF - GNTA
28%
Poorly correlated
N/A
DRUG - GNTA
27%
Poorly correlated
+0.71%
PTHS - GNTA
25%
Poorly correlated
+1.68%
RLFTF - GNTA
24%
Poorly correlated
+3.89%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
+1.68%
SONN - PTHS
70%
Closely correlated
N/A
KLRS - PTHS
41%
Loosely correlated
+17.61%
LIXT - PTHS
34%
Loosely correlated
-3.62%
MBIO - PTHS
29%
Poorly correlated
-0.62%
INKT - PTHS
29%
Poorly correlated
+2.57%
More